Safety Rates Drug Report: LAMIVUDINE. Exposure during breast feeding adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: LAMIVUDINE. Injury: Exposure during breast feeding Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 12 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
126282221	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
126282491	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
126282571	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
126282591	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
126282621	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
126282771	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
126283311	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
126283671	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160808	IT
127460501	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160915	US
127461891	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160915	US
127461981	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160915	US
127462081	LAMIVUDINE.	Exposure during breast feeding	CIPLA	0.00		0	20160915	US

|< 1/2 << Previous Page Page 1

Total Records: 12 Number of Pages: 1

Execution Time: 0.056740045547485 seconds (ucode:5030145). Developed by: James D. Barger